See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2014_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 117,182,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,128,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,768,000 |
| 3 | remainder_Assets | 987,000 |
| 4 | LiabilitiesCurrent | 10,370,000 |
| 5 | LiabilitiesNoncurrent | 1,459,000 |
| 6 | remainder_Liabilities | 17,779,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,429,000 |
| 9 | ResearchAndDevelopmentExpense | 29,942,000 |
| 10 | remainder_Expenses | 13,000 |
| 11 | remainder_Revenues | 19,861,000 |
| 12 | remainder_NetIncome | -1,145,000 |
| 13 | remainder_ComprehensiveNetIncome | 36,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 123,065,000 |
| 1 | Liabilities | 29,608,000 |
| 2 | Expenses | 37,384,000 |
| 3 | Revenues | 19,861,000 |
| 4 | StockholdersEquity | 93,457,000 |
| 5 | NetIncome | -18,668,000 |
| 6 | ComprehensiveNetIncome | -18,650,000 |
| 7 | BaseVar | 105,549,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.42 |
| 9 | EconomicCapitalRatio | 3.31 |